TriMas (TRS) to Release Quarterly Earnings on Tuesday

TriMas (NASDAQ:TRS - Get Free Report) is anticipated to post its Q2 2025 quarterly earnings results before the market opens on Tuesday, July 29th. Analysts expect TriMas to post earnings of $0.50 per share and revenue of $251.18 million for the quarter. TriMas has set its FY 2025 guidance at 1.700-1.850 EPS.

TriMas (NASDAQ:TRS - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. The business had revenue of $241.67 million for the quarter, compared to the consensus estimate of $235.41 million. TriMas had a return on equity of 10.54% and a net margin of 3.36%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.37 earnings per share. On average, analysts expect TriMas to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

TriMas Stock Up 0.8%

Shares of TRS stock traded up $0.25 during trading hours on Tuesday, reaching $30.81. 256,121 shares of the company's stock were exchanged, compared to its average volume of 365,723. The stock's 50 day moving average is $27.39 and its 200-day moving average is $24.62. The company has a market cap of $1.25 billion, a price-to-earnings ratio of 17.46 and a beta of 0.63. The company has a current ratio of 2.82, a quick ratio of 1.49 and a debt-to-equity ratio of 0.63. TriMas has a fifty-two week low of $19.33 and a fifty-two week high of $31.66.

Insider Buying and Selling at TriMas

In other news, Director Adrianne Shapira bought 4,000 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average cost of $25.82 per share, with a total value of $103,280.00. Following the transaction, the director directly owned 8,476 shares in the company, valued at approximately $218,850.32. The trade was a 89.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Shawn Sedaghat bought 410,172 shares of the business's stock in a transaction that occurred on Wednesday, May 21st. The stock was purchased at an average cost of $25.43 per share, for a total transaction of $10,430,673.96. Following the completion of the transaction, the director owned 1,810,821 shares in the company, valued at $46,049,178.03. This trade represents a 29.28% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 971,649 shares of company stock worth $24,585,343. 14.20% of the stock is owned by insiders.

Institutional Investors Weigh In On TriMas

A hedge fund recently raised its stake in TriMas stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of TriMas Corporation (NASDAQ:TRS - Free Report) by 4.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,120 shares of the industrial products company's stock after acquiring an additional 1,014 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.06% of TriMas worth $565,000 as of its most recent SEC filing. Institutional investors and hedge funds own 99.42% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on TRS shares. BWS Financial reaffirmed a "buy" rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday, April 30th. Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.